Cat#:RP-1777H;Product Name:Recombinant Human FGF8a / FGF8a Protein;Synonym:NEWENTRY;Description:A DNA sequence encoding the human FGF8a (NP_149355.1) (Gln23-Arg204) was expressed with an initial Met.;Source:E. coli;Predicted N Terminal:Met;Molecular Characterization:The recombinant human FGF8a consists 183 amino acids and predicts a molecular mass of 21.3 kDa.;Purity:Greater than 95 % as determined by SDS-PAGE.;Endotoxin:Please contact us for more information.;Bioactivity:Please contact us for detailed information;Formulation:Lyophilized from sterile 20 mM Tris, 500 mM NaCl, pH 8.5.;Stability:Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃;Reconstitution:Please see related COA for specific instructions.;Storage:Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -83℃).;
A DNA sequence encoding the human FGF8a (NP_149355.1) (Gln23-Arg204) was expressed with an initial Met.
Source:
E. coli
Predicted N Terminal:
Met
Molecular Characterization:
The recombinant human FGF8a consists 183 amino acids and predicts a molecular mass of 21.3 kDa.
Purity:
Greater than 95 % as determined by SDS-PAGE.
Endotoxin:
Please contact us for more information.
Bioactivity:
Please contact us for detailed information
Formulation:
Lyophilized from sterile 20 mM Tris, 500 mM NaCl, pH 8.5.
Stability:
Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃
Reconstitution:
Please see related COA for specific instructions.
Storage:
Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -83℃).